Treatment of rheumatoid arthritis include:
First, the core concept here is rheumatoid arthritis treatment. The mainstay includes DMARDs like methotrexate, biologics such as TNF inhibitors, and NSAIDs for symptoms. Corticosteroids are also used. I need to structure the explanation around these points.
For the correct answer, let's assume the options include methotrexate, which is a first-line DMARD. The correct answer would be methotrexate. Then the explanation would detail its mechanism of action, like inhibiting dihydrofolate reductase, leading to reduced purine synthesis and immune cell proliferation. Also, its role in slowing joint damage.
The wrong options might include NSAIDs like ibuprofen, which are used for pain and inflammation but don't modify disease progression. Biologics like adalimumab are correct but maybe the question is about first-line. Corticosteroids are used for acute flares but not long-term. So each incorrect option needs a reason why it's not the best choice.
The clinical pearl should highlight methotrexate as first-line and the hierarchy of treatments. Also, mention the importance of DMARDs in preventing joint destruction.
Need to make sure all sections are covered: Core Concept, Why Correct, Why Wrong, Clinical Pearl, and Correct Answer. Keep each section concise, under the character limit. Check for precise medical terms and avoid markdown except bold for sections. Also, ensure the correct answer line is at the end.
**Core Concept**
Rheumatoid arthritis (RA) is an autoimmune disorder characterized by synovial inflammation and joint destruction. Treatment aims to induce remission, prevent joint damage, and manage symptoms. First-line therapies include disease-modifying antirheumatic drugs (DMARDs), biologics, and corticosteroids.
**Why the Correct Answer is Right**
Methotrexate is the cornerstone of RA treatment due to its efficacy in slowing disease progression. It inhibits dihydrofolate reductase, reducing purine synthesis and suppressing overactive immune cell proliferation. This decreases pro-inflammatory cytokines (e.g., TNF-Ξ±, IL-6) and synovial inflammation, preserving joint structure. It is preferred for its cost-effectiveness and well-established safety profile.
**Why Each Wrong Option is Incorrect**
**Option A:** Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen reduce pain and inflammation but do not alter disease progression. **Option B:** Corticosteroids (e.g., prednisone) provide rapid anti-inflammatory effects but are reserved for short-term use due to side effects. **Option C:** Biologics (e.g., adalimumab) are second-line agents for patients with inadequate response to DMARDs. **Option D:** Analgesics like paracetamol only manage symptoms without modifying the disease.
**Clinical Pearl / High-Y